1. Assumptions, conjectures, and other miracles: The application of evaluative thinking to theory of change models in community development. (December 2016) Authors: Archibald, Thomas; Sharrock, Guy; Buckley, Jane; Cook, Natalie Journal: Evaluation and program planning Issue: Volume 59(2016:Dec.) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assumptions, conjectures, and other miracles: The application of evaluative thinking to theory of change models in community development. (December 2016) Authors: Archibald, Thomas; Sharrock, Guy; Buckley, Jane; Cook, Natalie Journal: Evaluation and program planning Issue: Volume 59(2016:Dec.) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice. Issue 6 (9th December 2011) Authors: Gopinathan, Aarthi; DeNicola, Gina M; Frese, Kristopher K; Cook, Natalie; Karreth, Florian A; Mayerle, Julia; Lerch, Markus M; Reinheckel, Thomas; Tuveson, David A Journal: Gut Issue: Volume 61:Issue 6(2012) Page Start: 877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials. (11th May 2015) Authors: Hansen, Aaron R.; Cook, Natalie; Ricci, M. Stacey; Razak, Albiruni; Le Tourneau, Christophe; McKeever, Kathleen; Roskos, Lorin; Dixit, Rakesh; Siu, Lillian L.; Hinrichs, Mary Jane Journal: Oncologist Issue: Volume 20:Number 6(2015) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Choice of Starting Dose for Biopharmaceuticals in First‐in‐Human Phase I Cancer Clinical Trials. (11th May 2015) Authors: Hansen, Aaron R.; Cook, Natalie; Ricci, M. Stacey; Razak, Albiruni; Le Tourneau, Christophe; McKeever, Kathleen; Roskos, Lorin; Dixit, Rakesh; Siu, Lillian L.; Hinrichs, Mary Jane Journal: Oncologist Issue: Volume 20:Number 6(2015) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer. (10th July 2019) Authors: Tinsley, Nadina; Zhou, Cong; Tan, Grace; Rack, Samuel; Lorigan, Paul; Blackhall, Fiona; Krebs, Matthew; Carter, Louise; Thistlethwaite, Fiona; Graham, Donna; Cook, Natalie Journal: Oncologist Issue: Volume 25:Number 1(2020) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Determinants of the recommended phase 2 dose of molecular targeted agents. Issue 8 (9th February 2017) Authors: Hansen, Aaron R.; Cook, Natalie; Amir, Eitan; Siu, Lillian L.; Abdul Razak, Albiruni Ryan Journal: Cancer Issue: Volume 123:Issue 8(2017) Page Start: 1409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Early phase clinical trials to identify optimal dosing and safety. Issue 5 (14th August 2014) Authors: Cook, Natalie; Hansen, Aaron R.; Siu, Lillian L.; Abdul Razak, Albiruni R. Other Names: Mendelsohn John specialEditor.; Ringborg Ulrik specialEditor.; Schilsky Richard specialEditor. Journal: Molecular oncology Issue: Volume 9:Issue 5(2015:May) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Enrolment of older adults with cancer in early phase clinical trials—an observational study on the experience in the north west of England. (9th June 2021) Authors: Gomes, Fabio; Descamps, Tine; Lowe, Jessica; Little, Martin; Lauste, Rosie; Krebs, Matthew G; Graham, Donna; Thistlethwaite, Fiona; Carter, Louise; Cook, Natalie Journal: Age and ageing Issue: Volume 50:Number 5(2021) Page Start: 1736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors. (April 2021) Authors: Falchook, Gerald; Infante, Jeffrey; Arkenau, Hendrik-Tobias; Patel, Manish R.; Dean, Emma; Borazanci, Erkut; Brenner, Andrew; Cook, Natalie; Lopez, Juanita; Pant, Shubham; Frankel, Arthur; Schmid, Peter; Moore, Kathleen; McCulloch, William; Grimmer, Katharine; O'Farrell, Marie; Kemble, George; Bu... Journal: EClinicalMedicine Issue: Volume 34(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗